All
Opdivo Plus Chemo May Be Effective and Safe in Older Patients with cHL
Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.
Krazati and Erbitux Effective for KRAS G12C-Mutant Advanced mCRC
Findings presented at the Gastrointestinal Cancers Symposium showed the efficacy of Krazati and Erbitux for some patients with unresectable or metastatic colorectal cancer.
Erleada Combo Shows Comparable Quality of Life Outcomes in Prostate Cancer
A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.
FDA-Approved Calquence Combo Is First and Only of Its Kind in MCL
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor approved for first line therapy.
You Need Tough Skin With Cancer
Living with lymphoma for 15 years, I developed a concerning rash post-vacation, which led to a leukocytoclastic vasculitis diagnosis.
Welireg With Cabometyx Elicits Promising First-Line Responses in ccRCC
Researchers have published findings from the phase 2 LITESPARK-003 study of patients with previously untreated advanced clear-cell renal cell carcinoma.
Palliative Care May Reduce Invasive Intervention Use in Early-Onset CRC
Palliative care for young adults with colorectal cancer reduced invasive procedures, costs and increased DNR orders.
Circulating Tumor DNA May Have Prognostic Value in Kidney Cancer
Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ctDNA.
Pancreatic Cancer Diagnoses and Mortality Rates Rise
The recent American Cancer Society’s Cancer Statistics, 2025 report was released revealing a sobering trend for pancreatic cancer.
Bold Goal, Bold Action
As we observe World Cancer Day, I’m reflecting on my own family’s experience with blood cancer.
What is Breast Cancer Rehab?
Cancer rehab is a fairly new and growing specialty in the therapy world.
A Patient-Centered Approach to Plastic Surgery Reconstruction
Breast cancer surgery is a deeply personal and often challenging experience for many women.
Nutrition After a Cancer Diagnosis
If you’re reading this, you recognize the importance of diet and nutrition after a cancer diagnosis.
Addressing the Unique Challenges of Breast Cancer in People Under 40
Statistics show that breast cancer is most common in women over 50, but that doesn’t mean it can’t affect individuals outside that age range.
Learn to Advocate for the Cancer Community with Triage Cancer
Join Triage Cancer for their free webinar on Post-Election Advocacy: Getting Engaged.
Neoadjuvant Tyvyt With Chemo Improve Responses in Resectable, Locally Advanced ESCC
In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an improvement in response rates.
When Cancer Makes You Cry, Cry It Out
Even stoics need to cry now and then. My advice from personal experience is this: it is okay to cry.
World Cancer Day Shines Light on Therapeutic Advancements in Cancer Care
Dr. John Oertle discussed the significance of World Cancer Day, raising awareness about cancer care advancements and improving patient outcomes.
Weight Gain Measurements May Be Underreported in ALK+ NSCLC Trials
Alecensa weight gain is underreported in ALK+ NSCLC trials, highlighting the need for increased awareness and proactive management of this side effect.
Tevimbra Plus Chemo May Be Safe, Effective in Advanced Gastric/GEJ Cancer
Frontline treatment with Tevimbra plus irinotecan, paclitaxel, oxaliplatin and 5-FU/leucovorin had promising efficacy and manageable safety in gastric/GEJ cancer.
Rybrevant Alone and in Combo With Chemo is Efficacious in Wildtype+ mCRC
Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.
Breast Cancer Sucks But Sometimes Thoughtfulness Can Make It Better
Breast cancer affected my looks and self-esteem, but I found small things could make a big difference in feeling pretty again.
Breaking Down Cancer Therapies Approved by the FDA in January 2025
Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.
Cabometyx Demonstrates PFS Benefit Versus Placebo in GI-NETs
Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced gastrointestinal NETs.
ITM-11 Meets Phase 3 Trial Primary End Point of PFS in GEP-NETs
Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive grade 1 or grade 2 GEP-NETs.
The Tap on the Shoulder: Cancer's Unexpected Call
After a second breast cancer diagnosis at 61, I faced 17 rounds of chemo, surgery and radiation, changing my perspective on life and leading to a new normal.
Tevimbra Plus Chemotherapy May Improve Survival in First-Line ESCC
Early and late responders with esophageal squamous cell carcinoma experienced comparable OS benefits with Tevimbra plus chemo in the RATIONALE-306 trial.
New Trial to Test Light Therapy Plus Keytruda in Head and Neck Cancer
A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck squamous cell carcinoma.
Breaking Down the Safety of BCG in Patients With NMIBC
BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with chemo, fewer were reported.
Why Hope is Important For Patients with Chronic Lymphocytic Leukemia
Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's challenges.